BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35732500)

  • 21. Multifocal nerve lesions and LZTR1 germline mutations in segmental schwannomatosis.
    Farschtschi S; Mautner VF; Pham M; Nguyen R; Kehrer-Sawatzki H; Hutter S; Friedrich RE; Schulz A; Morrison H; Jones DT; Bendszus M; Bäumer P
    Ann Neurol; 2016 Oct; 80(4):625-8. PubMed ID: 27472264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vestibular schwannomas occur in schwannomatosis and should not be considered an exclusion criterion for clinical diagnosis.
    Smith MJ; Kulkarni A; Rustad C; Bowers NL; Wallace AJ; Holder SE; Heiberg A; Ramsden RT; Evans DG
    Am J Med Genet A; 2012 Jan; 158A(1):215-9. PubMed ID: 22105938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immortalized Human Schwann Cell Lines Derived From Tumors of Schwannomatosis Patients.
    Ostrow KL; Donaldson K; Blakeley J; Belzberg A; Hoke A
    PLoS One; 2015; 10(12):e0144620. PubMed ID: 26657314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical features of spinal schwannomas in 65 patients with schwannomatosis compared with 831 with solitary schwannomas and 102 with neurofibromatosis Type 2: a retrospective study at a single institution.
    Li P; Zhao F; Zhang J; Wang Z; Wang X; Wang B; Yang Z; Yang J; Gao Z; Liu P
    J Neurosurg Spine; 2016 Jan; 24(1):145-54. PubMed ID: 26407091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 2 and Related Disorders.
    Evans DGR; Salvador H; Chang VY; Erez A; Voss SD; Druker H; Scott HS; Tabori U
    Clin Cancer Res; 2017 Jun; 23(12):e54-e61. PubMed ID: 28620005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Creation of an international registry to support discovery in schwannomatosis.
    Ostrow KL; Bergner AL; Blakeley J; Evans DG; Ferner R; Friedman JM; Harris GJ; Jordan JT; Korf B; Langmead S; Leschziner G; Mautner V; Merker VL; Papi L; Plotkin SR; Slopis JM; Smith MJ; Stemmer-Rachamimov A; Yohay K; Belzberg AJ
    Am J Med Genet A; 2017 Feb; 173(2):407-413. PubMed ID: 27759912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LZTR1-related spinal schwannomatosis and 7q11.23 duplication syndrome: A complex phenotype with dual diagnosis.
    Muthusamy K; Mrugala MM; Bendok BR; Dhamija R
    Mol Genet Genomic Med; 2021 Jan; 9(1):e1560. PubMed ID: 33269527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A germline missense mutation in COQ6 is associated with susceptibility to familial schwannomatosis.
    Zhang K; Lin JW; Wang J; Wu X; Gao H; Hsieh YC; Hwu P; Liu YR; Su L; Chiou HY; Wang D; Yuan YC; Whang-Peng J; Chiu WT; Yen Y
    Genet Med; 2014 Oct; 16(10):787-92. PubMed ID: 24763291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA-based analysis of two SMARCB1 mutations associated with familial schwannomatosis with meningiomas.
    Melean G; Velasco A; Hernández-Imaz E; Rodríguez-Álvarez FJ; Martín Y; Valero A; Hernández-Chico C
    Neurogenetics; 2012 Aug; 13(3):267-74. PubMed ID: 22752724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Schwannomatosis: a new member of neurofibromatosis family.
    Chen SL; Liu C; Liu B; Yi CJ; Wang ZX; Rong YB; Zhu J; Ding Y; Tian GL
    Chin Med J (Engl); 2013 Jul; 126(14):2656-60. PubMed ID: 23876891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Rare Case of Familial Schwannomatosis Showing Intrafamilial Variability with Identification of a Shared Novel Germline
    Lee JH; Jeong JS; Chae KJ; Han YH; Kim SR; Lee YC
    Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36363549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis.
    Rousseau G; Noguchi T; Bourdon V; Sobol H; Olschwang S
    BMC Neurol; 2011 Jan; 11():9. PubMed ID: 21255467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Broadening the spectrum of SMARCB1-associated malignant tumors: a case of uterine leiomyosarcoma in a patient with schwannomatosis.
    Paganini I; Sestini R; Cacciatore M; Capone GL; Candita L; Paolello C; Sbaraglia M; Dei Tos AP; Rossi S; Papi L
    Hum Pathol; 2015 Aug; 46(8):1226-31. PubMed ID: 26001331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic Pathology of Tumors of Peripheral Nerve.
    Belakhoua SM; Rodriguez FJ
    Neurosurgery; 2021 Feb; 88(3):443-456. PubMed ID: 33588442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SMARCB1 involvement in the development of leiomyoma in a patient with schwannomatosis.
    Hulsebos TJ; Kenter S; Siebers-Renelt U; Hans V; Wesseling P; Flucke U
    Am J Surg Pathol; 2014 Mar; 38(3):421-5. PubMed ID: 24525513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of Germline Mutations of the SMARCB1 Gene in a Chinese Family with Intraspinal Schwannomatosis.
    Ding Y; Rong H; Wang Y; Liu T; Zhang J; Li S; Wang Z; Wang Y; Zhu T
    World Neurosurg; 2019 Mar; 123():318-322. PubMed ID: 30576819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Segmental schwannomatosis: characteristics in 12 patients.
    Alaidarous A; Parfait B; Ferkal S; Cohen J; Wolkenstein P; Mazereeuw-Hautier J
    Orphanet J Rare Dis; 2019 Aug; 14(1):207. PubMed ID: 31438995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Secretomes of Painful Versus Nonpainful Human Schwannomatosis Tumor Cells Differentially Influence Sensory Neuron Gene Expression and Sensitivity.
    Ostrow KL; Donaldson KJ; Caterina MJ; Belzberg A; Hoke A
    Sci Rep; 2019 Sep; 9(1):13098. PubMed ID: 31511601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas.
    Hadfield KD; Smith MJ; Urquhart JE; Wallace AJ; Bowers NL; King AT; Rutherford SA; Trump D; Newman WG; Evans DG
    Oncogene; 2010 Nov; 29(47):6216-21. PubMed ID: 20729918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular Analysis of Hybrid Neurofibroma/Schwannoma Identifies Common Monosomy 22 and α-T-Catenin/CTNNA3 as a Novel Candidate Tumor Suppressor.
    Stahn V; Nagel I; Fischer-Huchzermeyer S; Oyen F; Schneppenheim R; Gesk S; Bohring A; Chikobava L; Young P; Gess B; Werner M; Senner V; Harder A
    Am J Pathol; 2016 Dec; 186(12):3285-3296. PubMed ID: 27765635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.